Dimensional Fund Advisors LP Purchases 710,908 Shares of Nutrien Ltd. $NTR

Dimensional Fund Advisors LP boosted its position in shares of Nutrien Ltd. (NYSE:NTR - Free Report) by 16.9% in the first quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 4,923,879 shares of the company's stock after acquiring an additional 710,908 shares during the quarter. Dimensional Fund Advisors LP owned 1.01% of Nutrien worth $244,583,000 at the end of the most recent reporting period.

Other institutional investors also recently bought and sold shares of the company. Barclays PLC increased its position in shares of Nutrien by 192.7% during the 4th quarter. Barclays PLC now owns 411,056 shares of the company's stock valued at $18,395,000 after purchasing an additional 854,543 shares during the last quarter. CANADA LIFE ASSURANCE Co increased its holdings in Nutrien by 7.8% during the fourth quarter. CANADA LIFE ASSURANCE Co now owns 297,113 shares of the company's stock valued at $13,254,000 after buying an additional 21,451 shares during the last quarter. Capital International Investors raised its position in Nutrien by 0.9% in the fourth quarter. Capital International Investors now owns 1,907,301 shares of the company's stock worth $85,344,000 after acquiring an additional 16,948 shares during the period. Capital Research Global Investors raised its position in Nutrien by 0.3% in the fourth quarter. Capital Research Global Investors now owns 1,124,178 shares of the company's stock worth $50,307,000 after acquiring an additional 3,589 shares during the period. Finally, Capital International Inc. CA bought a new stake in shares of Nutrien during the 4th quarter valued at $15,221,000. Institutional investors own 63.10% of the company's stock.

Nutrien Trading Up 0.3%

Shares of NTR stock opened at $57.10 on Monday. The company has a current ratio of 1.33, a quick ratio of 0.85 and a debt-to-equity ratio of 0.39. The stock has a market capitalization of $27.80 billion, a price-to-earnings ratio of 20.47, a price-to-earnings-growth ratio of 0.98 and a beta of 0.81. Nutrien Ltd. has a 12-month low of $43.69 and a 12-month high of $65.08. The stock's 50-day moving average price is $59.57 and its 200-day moving average price is $55.53.

Nutrien (NYSE:NTR - Get Free Report) last released its quarterly earnings results on Wednesday, August 6th. The company reported $2.65 earnings per share for the quarter, beating the consensus estimate of $2.41 by $0.24. The business had revenue of $10.30 billion during the quarter, compared to analysts' expectations of $10.40 billion. Nutrien had a return on equity of 6.51% and a net margin of 5.25%. The firm's revenue for the quarter was up 2.8% compared to the same quarter last year. During the same quarter last year, the business posted $2.34 EPS. Equities research analysts predict that Nutrien Ltd. will post 3.72 EPS for the current fiscal year.

Nutrien Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, October 17th. Shareholders of record on Monday, September 29th will be given a dividend of $0.545 per share. The ex-dividend date is Monday, September 29th. This represents a $2.18 annualized dividend and a yield of 3.8%. Nutrien's dividend payout ratio (DPR) is 78.14%.

Wall Street Analyst Weigh In

NTR has been the topic of a number of recent research reports. Raymond James Financial cut Nutrien from an "outperform" rating to a "market perform" rating and set a $68.00 target price on the stock. in a report on Tuesday, June 17th. The Goldman Sachs Group raised their price objective on Nutrien from $53.00 to $59.00 and gave the stock a "sell" rating in a research note on Friday, May 9th. Barclays boosted their price objective on Nutrien from $61.00 to $64.00 and gave the company an "equal weight" rating in a research note on Monday, July 7th. Oppenheimer raised their target price on shares of Nutrien from $63.00 to $65.00 and gave the stock an "outperform" rating in a research note on Tuesday, July 15th. Finally, Wall Street Zen upgraded shares of Nutrien from a "hold" rating to a "strong-buy" rating in a research report on Saturday, August 9th. One investment analyst has rated the stock with a sell rating, nine have issued a hold rating, six have given a buy rating and two have given a strong buy rating to the company. According to data from MarketBeat, the company currently has an average rating of "Moderate Buy" and an average price target of $62.65.

About Nutrien

Nutrien Ltd. provides crop inputs and services. The company operates through four segments: Retail, Potash, Nitrogen, and Phosphate. The Retail segment distributes crop nutrients, crop protection products, seeds, and merchandise products. The Potash segment provides granular and standard potash products.

Want to see what other hedge funds are holding NTR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Nutrien Ltd. (NYSE:NTR - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.